AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER.
D000477:Alkylating Agents; D000577:Amides; D000970:Antineoplastic Agents; D001389:Azirines; D035843:Biomedical Research; D001943:Breast Neoplasms; D004358:Drug Therapy; D006571:Heterocyclic Compounds; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D010721:Phosphinic Acids; D013844:Thiazoles; D014116:Toxicology
D000477:Alkylating Agents; D000577:Amides; D000970:Antineoplastic Agents; D001389:Azirines; D006571:Heterocyclic Compounds; D010721:Phosphinic Acids; D013844:Thiazoles; C025817:azetepa
ALKYLATING AGENTS; AMIDES; ANTINEOPLASTIC AGENTS; AZETEPA; AZIRINES; BREAST NEOPLASMS; CLINICAL RESEARCH; DRUG THERAPY; HETEROCYCLIC COMPOUNDS; NEOPLASM THERAPY; PHOSPHINIC ACIDS; THIAZOLES; TOXICOLOGIC REPORT